ロード中...
Pharmacokinetics of alectinib and its metabolite M4 in a patient with advanced lung adenocarcinoma undergoing hemodialysis: A case report
Abstract This study presents the first detailed pharmacokinetic data of alectinib and its metabolite M4 in a patient with anaplastic lymphoma kinase (ALK)‐rearranged lung adenocarcinoma undergoing hemodialysis. When the patient was administered a daily 300 mg bid dose of alectinib, the maximal obser...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley
2022-04-01
|
| シリーズ: | Thoracic Cancer |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1111/1759-7714.14357 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|